The role of heparin anticoagulation during intra-aortic balloon counterpulsation in the coronary care unit

Acute Cardiac Care

Volumn 10, Issue 4, 2008, Pages 214-220

  Cooper, Howard A ^a   Thompson, Elissa ^a   Panza, Julio A ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Hemorrhage; Heparin; Intra aortic balloon counterpulsation; Ischemia

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; AORTA BALLOON; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CONTINUOUS HEMODIALYSIS; CONTROL GROUP; CONTROLLED STUDY; CORONARY CARE UNIT; COUNTERPULSATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG FATALITY; DRUG INDICATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HUMAN; INCIDENCE; INTRACARDIAC THROMBOSIS; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE THROMBOSIS; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CORONARY CARE UNITS; FEMALE; HEMORRHAGE; HEPARIN; HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; ISCHEMIA; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 56749185675     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940802483048     Document Type: Article

References (10)

1. Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006;97:1391-8.
2. Arceo A, Urban P, Dorsaz PA, Chatelain P, Verin V, Suilen C, et al. In-hospital complications of percutaneous intraaortic balloon counterpulsation. Angiology 2003;54:577-85.
3. Cohen M, Ferguson JJ, 3rd, Freedman RJ, Jr, Miller MF, Reddy RC, Ohman EM, et al. Comparison of outcomes after 8 vs. 9.5 French size intra-aortic balloon counterpulsation catheters based on 9,332 patients in the prospective benchmark registry. Catheter Cardiovasc Interv. 2002;56:200-6.
4. Scholz KH, Ragab S, von zur Muhlen F, Schroder T, Werner GS, Mindel L, et al. Complications of intra-aortic balloon counterpulsation. The role of catheter size and duration of support in a multivariate analysis of risk. Eur Heart J. 1998;19:458-65.
5. Stone GW, Ohman EM, Miller MF, Joseph DL, Christenson JT, Cohen M, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol. 2003;41:1940-5.
6. Ferguson JJ, 3rd, Cohen M, Freedman RJ, Jr, Stone GW, Miller MF, Joseph DL, et al. The current practice of intraaortic balloon counterpulsation: results from the benchmark registry. J Am Coll Cardiol. 2001;38:1456-62.
7. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-82.
8. Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1193-204.
9. Meisel S, Shochat M, Sheikha SA, Osipov A, Kogan A, Anabussi N, et al. Utilization of low-profile intra-aortic balloon catheters inserted by the sheathless technique in acute cardiac patients: clinical efficacy with a very low complication rate. Clin Cardiol. 2004;27:600-4.
10. Jiang CY, Zhao LL, Wang JA, Mohammod B. Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anti-coagulation? J Zhejiang Univ Sci. 2003;4:607-11.